Skip to content

Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography

Retinal Vascular Manifestations in Patients With Common Internal Diseases on Optical Coherence Tomography Angiography

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05644548
Enrollment
300
Registered
2022-12-09
Start date
2022-03-01
Completion date
2028-12-31
Last updated
2025-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Dyslipidemias, Hypertension

Keywords

OCTA, Hypertension, Diabetes, Dyslipidemias

Brief summary

Hypertension, diabetes mellitus, and dyslipidemia are common internal diseases, and all diseases are atherosclerosis risk factors. Previous studies applied color fundus photography to analyze retinal vascular changes (including exudation, hemorrhage, neovascularization, etc.) in patients with hypertension or diabetes, but the examination results could not be quantified. This study intends to apply optical coherence tomography angiography (OCTA) to examine retinal vessels. This method has the following advantages: 1) It can quantify vascular changes, and 2) It is noninvasive and reproducible for patients' follow-up. This study was designed to investigate retinal vascular changes in patients with hypertension, diabetes, and dyslipidemia on OCTA. We will collect the patients' general information (gender, age), comorbidities, medications, blood lipids, blood glucose, carotid ultrasound, ankle-brachial index, ambulatory blood pressure monitoring, color fundus photography, and OCTA results. We will follow up with the patients for five years and conduct the mentioned examinations once a year. We will also investigate the correlation between systemic atherosclerosis (such as coronary artery stenosis, and carotid artery stenosis) and retinal vasculopathy in patients with these diseases.

Detailed description

Patients with hypertension, diabetes mellitus, or dyslipidemia, who go to the department of geriatric medicine, Beijing Tongren Hospital from March 2022 to December 2023 will be included. We will collect general information, comorbidities, medication, laboratory tests, and examination results. These patients will be followed up for 5 years with a yearly collection of comorbidities, medication, laboratory tests, and examination results.

Interventions

OTHERNo intervention

No intervention

Sponsors

Beijing Tongren Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with hypertension * Or patients with diabetes * Or patients with dyslipidemia * Agree to participate in this study

Exclusion criteria

* Patients with malignant tumors * Patients with autoimmune diseases * Patients with immunodeficiency disease * Disagree to participate in this study

Design outcomes

Primary

MeasureTime frameDescription
Vascular density of the retinaup to 5 years of follow-up.percent

Secondary

MeasureTime frameDescription
the foveal avascular zone (FAZ) size of the retinaWhen participating in the study, and once a year during 5 years of follow-up.mm2

Countries

China

Contacts

Primary ContactYu He, MD
bluelight323@126.com+861058268320
Backup ContactMa Jinbao, MD
majinbao77@sina.com+861058268320

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026